Financials
| Half-year Report | Sep. 30, 2024 |
| Audited Financial Statements Year Ended 2023 | May. 07, 2024 |
| Full Text of Accounts | May. 07, 2024 |
| Final Results | May. 07, 2024 |
| ANNUAL REPORT AND FINANCIAL STATEMENTS | Nov. 02, 2023 |
| Half-year Report | Sep. 28, 2023 |
| Annual Financial Report | Jul. 13, 2023 |
Proxies
| Print of Ordinary and Special Resolutions | Jun. 28, 2024 |
| Result of AGM | Jun. 27, 2024 |
| Notice of AGM | Jun. 03, 2024 |
| Notice of Annual General Meeting | May. 16, 2023 |
| Results of AGM | Jun. 14, 2022 |
| Notice of Annual General Meeting | May. 20, 2022 |
Ownership Update
| Holding in Company | Mar. 28, 2025 |
| Director Dealings | Mar. 28, 2025 |
| Holding(s) in Company | Jan. 13, 2025 |
| Holding(s) in Company | Jan. 13, 2025 |
| Holding(s) in Company | May. 10, 2024 |
| NOTIFICATION OF MAJOR HOLDINGS | Apr. 10, 2024 |
| NOTIFICATION OF MAJOR HOLDINGS | Apr. 09, 2024 |
Announcements
| Launch of AI-Powered Partnership | Apr. 14, 2025 |
| Genflow Launches New Development Program | Apr. 10, 2025 |
| Institutional Investment | Mar. 26, 2025 |
| 2024 Highlights | Jan. 06, 2025 |
| Genflow Secures Non-Dilutive Financial Support | Oct. 22, 2024 |
| Strengthening of Pre-Clinical Efforts | Jun. 27, 2024 |
| Receipt of Grant Funding | Jun. 12, 2024 |
Prospectuses
| GENFLOW BIOSCIENCES PLC - Single prospectus | Jan. 07, 2022 |